Mortality and associated factors after initiation of pediatric antiretroviral treatment in the democratic republic of the congo

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 35-40

  Callens, Steven F J ^a,f   Shabani, Nicole ^b   Lusiama, Jean ^b   Lelo, Patricia ^b   Kitetele, Faustin ^c   Colebunders, Robert ^d   Gizlice, Ziya ^e   Edmonds, Andrew ^a   Van Rie, Annelies ^a   Behets, Frieda ^a  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF KINSHASA   (Congo)

^c Kalembe Lembe Pediatric Hospital   (Congo)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

antiretroviral treatment; Child; Democratic Republic of the Congo; HIV; malnutrition; mortality; sub Saharan Africa; survival

Indexed keywords

CD4 ANTIGEN; HEMOGLOBIN; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHILD; CONGO; DISEASE SEVERITY; DYING; FEMALE; HEALTH PROMOTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL; THRUSH;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; CANDIDIASIS, ORAL; CHILD; CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SHOCK, SEPTIC;

EID: 66149148223     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318184eeb9     Document Type: Article

References (59)

1. Arrive E, Kyabayinze DJ, Marquis B, et al. Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration. Int J Epidemiol. 2008;37:474-480.
2. George E, Noel F, Bois G, et al. Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis. 2007;195:1411-1418.
3. Coetzee D, Hilderbrand K, Boulle A, et al. Paediatric outcomes after 3 years in a primary care setting in South Africa. Paper presented at: XVI International AIDS Conference; 2006; Toronto, Canada. Abstract MOPE0223.
4. O'Brien DP, Sauvageot D, Olson D, et al. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resourcelimited settings. Clin Infect Dis. 2007;44:1245-1248.
5. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18: 1905-1913.
6. Janssens B, Raleigh B, Soeung S, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics. 2007;120:e1134-e1140.
7. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899.
8. Cardoso C, Dantas A, Dias A, et al. Dramatic reduction of mortality among HIV-infected children in Brazil after the introduction of highly active anti-retroviral therapy (HAART). Paper presented at: XVI International AIDS Conference; 2006; Toronto, Canada. Abstract CDB0040.
9. Alexander L, Mubiru A, Were W, et al. Virologic, immunologic and clinical outcomes in Ugandan children initiating antiretroviral treatment. Paper presented at: XVI International AIDS conference; 2006; Toronto, Canada. Abstract CDB0555.0
10. Sirinavin S, Atamasirikul K, Thititanyanont A, et al. Prognostic factors and long-term survival of Thai children with HIV-1 infection. Paper presented at: The XV International AIDS Conference; 2004; Bangkok, Thailand. Abstract TuPeB4451.1
11. Villamor E, Misegades L, Fataki MR, et al. Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol. 2005;34:61-68.2
12. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J. 2004;23:536-543.3
13. Taha TE, Kumwenda NI, Hoover DR, et al. Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS. 2000;14:453-459.4
14. Walker AS, Mulenga V, Sinyinza F, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr. 2006;42:637-645.5
15. 3Cs4kids Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a metaanalysis. AIDS. 2008;22:97-105.6
16. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-1810.7
17. Tumwesigye N, Kieffer M, Marquis B, et al. Response to antiretroviral therapy (ART) in children in sub-Saharan Africa: The KIDS-ART-LINC collaboration multicentre pooled analysis. Presented at: The 2007 HIV/AIDS Implementers' Meeting; 2007; Kigali, Rwanda. Abstract 1786.8
18. Lawn SD, Myer L, Harling G, et al. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006;43:770-776.9
19. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.0
20. Farmer PE, Nizeye B, Stulac S, et al. Structural violence and clinical medicine. PLoS Med. 2006;3:e449.1
21. Philbrick W, Wallace B, Neill T. Early childhood development: CARE'S ''5X5'' approach, a multi-sectoral pilot project to achieve maximum impact for the care and support of children ages 0-8 and their communities. Presented at: The 2007 HIV/AIDS Implementers' Meeting; June 16-19, 2007; Kigali, Rwanda. Abatract 1639.2
22. Havens PL, Gibb DM. Increasing antiretroviral drug access for children with HIV infection. Pediatrics. 2007;119:838-845.3
23. Kline MW. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics. 2006;117:1388-1393.
24. Coghlan B, Brennan RJ, Ngoy P, et al. Mortality in the Democratic Republic of Congo: a nationwide survey. Lancet. 2006;367:44-51.5
25. World Health Organization. Typhoid fever in the Democratic Republic of the Congo (2005)-Update 2005. Available at: http://www.who.int/csr/don/2005-01- 19/en/index.html. Accessed December 30, 2007.6
26. Grais RF, DE Radiguès X, Dubray C, et al. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect. 2006;134:845-849.7
27. Trefon T. Reinventing Order in the Congo: How People Respond to State Failure in Kinshasa. 1st ed. London and New York: Zed books; 2006.8
28. Ogden J, Esim S, Grown C. Expanding the care continuum for HIV/AIDS: bringing carers into focus. Health Policy Plan. 2006;21:333-342.9
29. Belgian Red Cross. Ho ̂pital pe ́diatrique de Kalembe Lembe Croix-Rouge de la Re ́publique Démocratique du Congo en partenariat avec la Croix-Rouge de Belgique. Version Provisiore. 2006. Available at: http://www.croix-rouge.be/UserFiles/File/Publications/plan-strategique-KLL.pdf. Accessed December 30, 2007.0
30. Hamill PV, Drizd TA, Johnson CL, et al. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979;32:607-629.1
31. Lin D, Wei L, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika. 1993;80:557-572.2
32. Rubin D. Multiple Imputation for Nonresponse in Surveys. 1st ed. New York, NY: John Wiley; 2004.3
33. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.4
34. Prendergast A, Tudor-Williams G, Jeena P, et al. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet. 2007; 370:68-80.5
35. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.6
36. Johannessen A, Naman E, Matee M, et al. Risk factors for early mortality on antiretroviral treatment in a rural hospital in Tanzania. Paper presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2007; Sydney, Australia. Abstract WEPEB054.7
37. Kambugu A, Castelnuovo B, Wandera B, et al. Antiretroviral therapy in an urban African cohort does not prevent significant early mortality. Paper presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2007; Sydney, Australia. Abstract WEPEB055.8
38. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics. 1999;104:e56.9
39. Marston M, Zaba B, Salomon JA, et al. Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr. 2005;38:219-227.0
40. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.1
41. Violari A, Cotton M, Gibb D, et al. Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants: evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. Paper presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2007; Sydney, Australia. Abstract WESS103.2
42. Sherman GG, Jones SA, Coovadia AH, et al. PMTCT from research to reality-results from a routine service. S Afr Med J. 2004;94:289-292.3
43. Anabwani G, Navario P. Nutrition and HIV/AIDS in sub-Saharan Africa: an overview. Nutrition. 2005;21:96-99.4
44. Sengoba J, Awori M, Blackham J, et al. Why are children still dying? Paper presented at: XVI International AIDS Conference; 2006; Toronto, Canada. Abstract CDB0053.5
45. United Nations Children's Fund. The State of the World's Children 2007. Women and Children: The Double Dividend of Gender Equality 2007 2006. Available at: http://www.unicef.org/sowc07/docs/sowc07.pdf. Accessed December 30, 2007.6
46. Ndagije F, Baribwira C, Coulter JB. Micronutrients and T-cell subsets: a comparison between HIV-infected and uninfected, severely malnourished Rwandan children. Ann Trop Paediatr. 2007;27:269-275.7
47. Bachou H, Tylleskar T, Downing R, et al. Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4- cell counts. Nutr J. 2006;5:27.8
48. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach September, 2007. Available at: http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf. Accessed December 30, 2007.9
49. Kessler L, Daley H, Malenga G, et al. The impact of the human immunode-ficiency virus type 1 on the management of severe malnutrition in Malawi. Ann Trop Paediatr. 2000;20:50-56.0
50. Bachou H, Tylleskar T, Kaddu-Mulindwa DH, et al. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda. BMC Infect Dis. 2006;6:160.1
51. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr. 2001;32:550-554.2
52. Scheutz F, Matee MI, Simon E, et al. Association between carriage of oral yeasts, malnutrition and HIV-1 infection among Tanzanian children aged 18 months to 5 years. Community Dent Oral Epidemiol. 1997;25:193-198.3
53. Monkemuller KE, Call SA, Lazenby AJ, et al. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol. 2000;95:457-462.4
54. Wilcox CM. Gastrointestinal manifestations of AIDS. Nutr Clin Pract. 2004;19:356-364.5
55. Garenne M, Fauveau V. Potential and limits of verbal autopsies. Bull World Health Organ. 2006;84:164.6
56. Lopman BA, Barnabas RV, Boerma JT, et al. Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med. 2006;3:e312.7
57. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis. 2007;44:599-604.8
58. Babirekere-Iriso E, Musoke P, Kekitiinwa A. Bacteraemia in severely malnourished children in an HIV-endemic setting. Ann Trop Paediatr. 2006;26: 319-328.9
59. World Health Organization. Child and Adolescent Health and Development: Resources: Integrated Management of Childhood Illness; September 26, 2006. Available at: http://www.who.int/child-adolescent-health/publications/pubIMCI. htm.